Improving the Science of Adherence Reinforcement and Safe Mobility in People With Diabetic Foot Ulcers Using Smart Offloading
概览
- 阶段
- 2 期
- 干预措施
- 未指定
- 疾病 / 适应症
- Diabetic Foot Ulcer
- 发起方
- University of Southern California
- 入组人数
- 210
- 试验地点
- 4
- 主要终点
- Wound healing at 12 weeks or sooner
- 状态
- 招募中
- 最后更新
- 3个月前
概览
简要总结
The purpose of this study is to help people with diabetes who develop neuropathic diabetic foot ulcers (DFUs). These ulcers, or sores, if left untreated can increase the chance of amputation. Part of the treatment is to have the person wear a diabetic shoe or boot to help their foot heal. Sometimes people don't wear the boot like they are told. The investigators want to compare three different kinds of diabetic boots to see if they can help make it easier for people to wear their boots as instructed.
The investigators will look at three groups of participants: the first group will use removable offloading with reinforced education emphasizing continuous wear, including during rest and sleep, and not to remove it at any time. The second group will use removable offloading consistent with standard of care and receive education on recommended wear during walking or standing, with permission to remove the device during rest and sleep. The third group will use a smart removable offloading device that provides real-time adherence feedback via a smartwatch and smartphone, with additional personalized education informed by remotely monitored adherence data.
The investigators will also be looking at how much physical activity, like walking, the participants do. And they will compare how well participants sleep and rate their quality of life in the three different boots. The investigators think that giving participants information about how much they are wearing their boot using readily available technology will help them to follow the doctor's directions better, and help their wounds heal faster.
研究者
David Armstrong
Professor
University of Southern California
入排标准
入选标准
- •Male or female
- •≥18 years old
- •Non-infected, non-ischemic DFU requiring offloading
- •Ambulatory at home with or without assistance
- •Willing and able to provide written informed consent
排除标准
- •Wound present for \> 1 year
- •HbA1c \> 12%
- •ABI of index limb \< 0.6 or non-detectable Doppler, and/or patient being considered for revascularization during the course of the study
- •Acute Charcot neuropathy or a major foot deformity that doesn't allow them to wear the smart boot
- •Amputation proximal to the rearfoot on the affected extremity
- •Any clinically significant medical or psychiatric condition
- •Laboratory abnormality that would interfere with the ability to participate in the study
- •Concurrently participating in exercise training
- •Changes in psychotropic or sleep medication in the last 6 weeks
- •Ulcer involves bone
结局指标
主要结局
Wound healing at 12 weeks or sooner
时间窗: Up to 12 weeks
Wound healing is defined as complete epithelialization of the target ulcer, confirmed by standardized wound assessment. Healing status is recorded as a binary outcome (yes/no) for each participant. The proportion of participants achieving wound healing by 12 weeks is compared between randomized treatment arms. Unit of Measure: %
Time to wound healing
时间窗: Up to 12 weeks
Time to wound healing is defined as the number of days from randomization to confirm complete epithelialization of the target ulcer, as determined by standardized wound assessment. Unit of Measure: Days
次要结局
- Patient acceptability(Week 12)
- Participant dropout rate(From baseline through Week 12)
- Adherence to offloading(From baseline through Week 12 (summarized weekly))
- Percentage of Wound Area Reduction(Percent reduction in wound area per week)